ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0044

Follistatin-like Protein 1 Alters T Cell Receptor Signaling Dynamics in Vitro, While Expression in Vivo Correlates with Disease and Deficiency Increases Acute Inflammation in a Mouse Model of Kawasaki Disease

Mateo Amezcua1, Janice Huang1, Miao Chen1, Renee Escalona2, Edward Dick2 and Mark Gorelik1, 1Columbia University, New York, NY, 2Texas Biomedical Research Institute, San Antonio, TX

Meeting: ACR Convergence 2022

Keywords: Cardiovascular, Pediatric rheumatology, T Cell, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Pediatric Rheumatology – Basic Science Poster

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Kawasaki disease (KD) is an acute, febrile illness of childhood, associated with cardiac inflammation and vasculitis of coronary arteries and sometimes other medium sized vessel. Follistatin-like protein 1 (FSTL-1) is markedly elevated in the serum of human patients with aneurysms in KD and appears to play a major role in cardiac physiology, however, the role of FSTL-1 in cardiac inflammation is unclear. FSTL-1 protein has been found to have an anti-inflammatory role in murine models of inflammatory arthritis. We sought to determine whether FSTL-1 deficiency would alter inflammatory responses in a mouse model of Kawasaki disease, as well as how T cell signaling was altered in the presence of FSTL-1 protein in culture.

Methods: Knockout (KO) of the FSTL-1 gene was achieved by using tamoxifen regulated Cre/loxP system, and verified by ELISA and RT-PCR. KD was induced via the lactobacillus casei cell wall extract (LCWE) murine model of KD. Post LCWE cytokine production was measured by multiplex immunoassay, and FSTL-1 levels by ELISA and Western blot. Inflammatory response in acute KD was quantified by blinded pathology review of cardiac histology and immunohistochemistry for CD3 and CD11c. Bulk RNA sequencing of cardiac tissue in knock out vs wild type mice was performed as well. Measurement of phosphorylation of multiple T cell receptor downstream proteins was performed via flow cytometry using stimulated T cells and other peripheral mononuclear cells.

Results: FSTL-1 serum levels were elevated four fold immediately following induction of KD and correlated with histologic disease severity and CD3 tissue infiltration. FSTL-1 gene expression was upregulated in cardiac tissue at the acute phase of inflammation. Measurement of glycosylated and non-glycosylated FSTL-1 protein in the cardiac tissue and serum showed upregulation of non-glycosylated FSTL-1 in the heart, while non-glycosylated FSTL-1 was not released systemically. Serum cytokine response was unchanged in FSTL-1 KO mice vs. WT mice in the immediate acute phase of disease. FSTL-1 deficiency was associated with worsened histologic inflammation and CD3 and CD11c tissue infiltration (p< 0.01). Bulk RNA sequencing revealed several highly downregulated genes with FSTL-1 knockout associated immunologic function and also with receptor recycling functions. Analysis of phosphorylation of multiple proteins downstream of the T cell receptor suggested alterations in the kinetics (ie, duration of activation) of ERK phosphorylation.

Conclusion: Knockout of FSTL-1 in the mouse model of Kawasaki disease resulted in increased inflammatory infiltrate in the peri-aortic and coronary tissue, and FSTL-1 expression in wild type mice appeared correlated with degree inflammation. This suggests a regulatory role for FSTL-1 in terms of inflammation in the heart. Altered gene expression of transcripts related to immune function and receptor recycling (endocytosis), along with altered kinetics of T cell receptor signaling may suggest that FSTL-1 may alter how surface receptors transmit down-stream signal, specifically in terms of sustained vs intermittent signal transmission.

Supporting image 1

Flow cytometry analysis of ERK phosphorylation in T cells (with peripheral blood mononuclear cells) shows altered signal kinetics between cells incubated with FSTL_1 protein and control settings.


Disclosures: M. Amezcua, None; J. Huang, None; M. Chen, None; R. Escalona, None; E. Dick, None; M. Gorelik, None.

To cite this abstract in AMA style:

Amezcua M, Huang J, Chen M, Escalona R, Dick E, Gorelik M. Follistatin-like Protein 1 Alters T Cell Receptor Signaling Dynamics in Vitro, While Expression in Vivo Correlates with Disease and Deficiency Increases Acute Inflammation in a Mouse Model of Kawasaki Disease [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/follistatin-like-protein-1-alters-t-cell-receptor-signaling-dynamics-in-vitro-while-expression-in-vivo-correlates-with-disease-and-deficiency-increases-acute-inflammation-in-a-mouse-model-of-kawasaki/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/follistatin-like-protein-1-alters-t-cell-receptor-signaling-dynamics-in-vitro-while-expression-in-vivo-correlates-with-disease-and-deficiency-increases-acute-inflammation-in-a-mouse-model-of-kawasaki/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology